文献速递肺血管病与心包/心肌炎心力衰竭与心肌病

左心疾病相关肺高血压不同血流动力学分类的预后比较

[Prognosis of different hemodynamic classifications in patients with pulmonary hypertension due to left heart disease].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2024-01-01

本研究为单中心前瞻性队列研究,纳入243例经右心导管确诊的PH-LHD患者,比较TPG、DPG和PVR三种分类方法对全因死亡的预测价值。中位随访57个月,101例(41.6%)死亡。PVR分类预测价值最优(AUC=0.698),TPG中等(AUC=0.596),DPG无预测价值(AUC=0.526)。

要点

  • PVR分类对PH-LHD患者全因死亡预测价值最优,AUC=0.698。
  • DPG分类对PH-LHD患者全因死亡无预测价值,AUC=0.526。
  • 年龄、PVR和log2NT-proBNP是全因死亡的独立危险因素。

核心结论

  • PVR分类方法对预测PH-LHD患者全因死亡最有价值,TPG分类方法表现出中等预测能力,DPG分类方法无预测价值。
  • 年龄、PVR和log2N末端B型利钠肽原是PH-LHD患者全因死亡的独立危险因素。

研究设计与样本

  • 单中心前瞻性队列研究,连续入选2013年9月至2019年12月在南京医科大学第一附属医院心血管内科经右心导管确诊的PH-LHD住院患者243例。
  • 患者年龄(54.9±12.7)岁,男性169例(69.5%),中位随访57个月。

主要发现

  • 随访期间101例(41.6%)发生全因死亡。
  • PVR(AUC=0.698,95%CI:0.631~0.766)较TPG(AUC=0.596,95%CI:0.523~0.669)和DPG(AUC=0.526,95%CI:0.452~0.601)对全因死亡有更好的预测价值(P<0.05)。
  • Kaplan-Meier分析显示按PVR或TPG分组的生存率组间差异有统计学意义(P<0.05),按DPG分组无统计学意义(P>0.05)。
  • 多因素Cox回归显示年龄、PVR和log2NT-proBNP是全因死亡的独立危险因素(P均<0.05)。

关键数值与推荐

  • TPG界值12 mmHg(1 mmHg=0.133 kPa),DPG界值7 mmHg,PVR界值3 Wood单位。
  • 约登指数计算的最佳临界值:TPG 13.9 mmHg、DPG 2.8 mmHg、PVR 3.8 Wood单位。
  • 分组:TPG≤12 mmHg组115例,TPG>12 mmHg组128例;DPG<7 mmHg组193例,DPG≥7 mmHg组50例;PVR≤3 Wood单位组108例,PVR>3 Wood单位组135例。
  • TPG≤12 mmHg且PVR≤3 Wood单位组89例,TPG>12 mmHg且PVR>3 Wood单位组109例。

临床怎么用

  • 在PH-LHD患者预后评估中,可优先采用PVR进行分类以识别高危患者。
  • TPG可作为中等预测能力的补充指标,DPG不推荐用于预后分类。
  • 年龄、PVR和log2NT-proBNP升高提示全因死亡风险增加,需加强随访管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To compare the prognostic values of different classification by using transpulmonary pressure gradient (TPG), diastolic pressure gradient (DPG) and pulmonary vascular resistance (PVR) in patients with pulmonary hypertension due to left heart disease (PH-LHD), and investigated hemodynamic and clinical factors associated with mortality in patients with PH-LHD. Methods: This was a single-center prospective cohort study. In-hospital patients diagnosed with PH-LHD via right heart catheterization at the Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, from September 2013 to December 2019 were enrolled. Patients were divided according to TPG (cutoff value 12 mmHg; 1 mmHg=0.133 kPa), DPG (cutoff value 7 mmHg), PVR (cutoff value 3 Wood Units), and the combination of TPG and PVR. Baseline characteristic was recorded. All patients were followed up until the occurrence of endpoint event, defined as all-cause death that occurred during the follow-up period, or until April 18, 2022. Receiver operating characteristic curves were used to compare the predictive value of 3 classification methods for all-cause death in PH-LHD patients. The optimal cutoff values were calculated using Jorden index. Survival analysis was performed using Kaplan-Meier analysis, and log-rank test was used to compare the predictive efficacy of classification methods based on optimal cutoff values or guidance-recommended thresholds for the survival of PH-LHD patients. Variables showing statistical significance in the univariate analysis were incorporated into multivariate Cox regression model to analyze the independent risk factors for all-cause mortality. Results: A total of 243 patients were enrolled, aged (54.9±12.7) years old, including 169 (69.5%) males. During a median follow-up of 57 months, there were 101 (41.6%) deaths occurred. Grouping results were as follows: (1) TPG: TPG≤12 mmHg group 115 patients, TPG>12 mmHg group 128 patients; (2) DPG: DPG<7 mmHg group 193 patients, DPG≥7 mmHg group 50 patients; (3) PVR: PVR≤3 Wood Units group 108 patients, PVR>3 Wood Units group 135 patients; (4) TPG and PVR: TPG≤12 mmHg and PVR≤3 Wood Units group 89 patients, TPG>12 mmHg and PVR>3 Wood Units group 109 patients. PVR (AUC=0. 698,95%CI:0.631-0.766) had better predictive value for all-cause mortality than TPG (AUC=0.596, 95%CI: 0.523-0.669) and DPG (AUC=0.526, 95%CI: 0.452-0.601) (all P<0.05). The optimal cutoff values for TPG, DPG, and PVR were13.9 mmHg, 2.8 mmHg, and 3.8 Wood Units, respectively. Kaplan-Meier analysis based on the optimal cutoff values or guidance-recommended thresholds showed that PVR and TPG were the predictors of survival (P<0.05), while DPG did not showed significance (P>0.05). Multivariate Cox regression analysis showed that age, PVR and log2N-terminal pro-B-type natriuretic peptide were independent risk factors for all-cause mortality in PH-LHD patients (all P<0.05). Conclusion: Classification according to PVR was most valuable in predicting all-cause death in PH-LHD patients, while TPG showed moderate predictive ability and DPG had no predictive value. 目的: 比较跨肺压差(TPG)、肺动脉舒张压差(DPG)和肺血管阻力(PVR)3种分类方法对左心疾病相关肺高血压(PH-LHD)患者预后的预测价值,探讨PH-LHD预后相关血流动力学和临床指标与患者全因死亡的关系。 方法: 本研究为单中心前瞻性队列研究。连续入选2013年9月至2019年12月在南京医科大学第一附属医院心血管内科经右心导管确诊的PH-LHD住院患者,依据TPG(界值12 mmHg;1 mmHg=0.133 kPa)、DPG(界值7 mmHg)、PVR(界值3 Wood单位)和TPG联合PVR对入选患者进行分组,收集患者基线临床资料。所有患者随访至发生终点事件或2022年4月18日,终点事件定义为随访期间发生的全因死亡。采用受试者工作特征曲线比较3种分类方法对PH-LHD患者全因死亡的预测价值。根据约登指数计算最佳临界值,采用Kaplan-Meier曲线进行生存分析,并使用log-rank检验比较依据最佳临界值或指南推荐的界值的分类方法对PH-LHD患者生存率的预测效力。将单因素分析中与全因死亡有关的变量纳入多因素Cox回归模型,分析PH-LHD患者全因死亡的独立危险因素。 结果: 共纳入243例患者,年龄(54.9±12.7)岁,男性169例(69.5%)。中位随访时间57个月,共101例(41.6%)发生终点事件。分组结果为:(1)依据TPG:TPG≤12 mmHg组115例,TPG>12 mmHg组128例;(2)依据DPG:DPG<7 mmHg组193例,DPG≥7 mmHg组50例;(3)依据PVR:PVR≤3 Wood单位组108例,PVR>3 Wood单位组135例;(4)依据TPG联合PVR:TPG≤12 mmHg且PVR≤3 Wood单位组89例,TPG>12 mmHg且PVR>3 Wood单位组109例。PVR(AUC=0.698,95%CI:0.631~0.766)较TPG(AUC=0.596,95%CI:0.523~0.669)和DPG(AUC=0.526,95%CI:0.452~0.601)对PH-LHD患者全因死亡有更好的预测价值(P<0.05)。根据约登指数计算的TPG、DPG和PVR的最佳临界值分别为13.9 mmHg、2.8 mmHg和3.8 Wood单位。Kaplan-Meier生存曲线分析显示,按PVR或TPG分组的患者生存率组间差异有统计学意义(P<0.05),按DPG分组的患者生存率组间差异无统计学意义(P>0.05)。多因素Cox回归分析结果显示,年龄、PVR和log2N末端B型利钠肽原是PH-LHD患者全因死亡的独立危险因素(P均<0.05)。 结论: PVR分类方法对预测PH-LHD患者全因死亡最有价值,TPG分类方法表现出中等预测能力,DPG分类方法对PH-LHD患者全因死亡无预测价值。年龄、PVR和log2N末端B型利钠肽原对预测PH-LHD患者全因死亡有价值。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Tang Y, Shi YP, Chen L, et al. [Prognosis of different hemodynamic classifications in patients with pulmonary hypertension due to left heart disease]. Zhonghua Xin Xue Guan Bing Za Zhi. 2024. PMID: 39428367. doi:10.3760/cma.j.cn112148-20240829-00492

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。